Design, physico-chemical characterization andin vitrobiological activity of organogold(iii) glycoconjugates

Andrea Pettenuzzo, Keti Vezzù, Maria Luisa Di Paolo, Eirini Fotopoulou, Luciano Marchiò, Lisa Dalla Via and Luca Ronconi

Dalton Trans., 2021, 50, 8963
DOI: 10.1039/D1DT01100F

Conjugation of a gold(iii) complex with vitamin B1 and chlorambucil derivatives: anticancer evaluation and mechanistic insights

Leila Tabrizi and Fatemeh Abyar

Metallomics, 2020, 12, 721
DOI: 10.1039/c9mt00304e

Cyclometalated gold(iii) complexes for chemoselective cysteine modification via ligand controlled C–S bond-forming reductive elimination

Karen Ka-Yan Kung, Hok-Ming Ko, Jian-Fang Cui, Hiu-Chi Chong, Yun-Chung Leung and Man-Kin Wong

Chem. Commun., 2014, 50, 11899
DOI: 10.1039/C4CC04467C

Chemical biology of anticancer gold(iii) and gold(i) complexes

Taotao Zou, Ching Tung Lum, Chun-Nam Lok, Jing-Jing Zhang and Chi-Ming Che

Chem. Soc. Rev., 2015, 44, 8786
DOI: 10.1039/C5CS00132C

Toward anticancer gold-based compounds targeting PARP-1: a new case study

A. Citta, V. Scalcon, P. Göbel, B. Bertrand, M. Wenzel, A. Folda, M. P. Rigobello, E. Meggers and A. Casini

RSC Adv., 2016, 6, 79147
DOI: 10.1039/C6RA11606J

A macromolecular cyclometalated gold(iii) amphiphile displays long-lived emissive excited state in water: self-assembly and in vitro photo-toxicity

Feng Wang, Minhuan Lan, Wai-Pong To, Kai Li, Chun-Nam Lok, Pengfei Wang and Chi-Ming Che

Chem. Commun., 2016, 52, 13273
DOI: 10.1039/C6CC06767K

Cyclometallated Au(iii) dithiocarbamate complexes: synthesis, anticancer evaluation and mechanistic studies

Morwen R. M. Williams, Benoît Bertrand, David L. Hughes, Zoë A. E. Waller, Claudia Schmidt, Ingo Ott, Maria O’Connell, Mark Searcey and Manfred Bochmann

Metallomics, 2018, 10, 1655
DOI: 10.1039/C8MT00225H

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

Benoît Bertrand and Angela Casini

Dalton Trans., 2014, 43, 4209
DOI: 10.1039/C3DT52524D

Design and Synthesis of Alanine Triazole Ligands and Application in Promotion of Hydration, Allene Synthesis and Borrowing Hydrogen Reactions

Yongchun Yang, Anni Qin, Keyan Zhao, Dawei Wang and Xiaodong Shi

Adv Synth Catal, 2016, 358, 1433
DOI: 10.1002/adsc.201600141

Structure–Activity Relationships in Cytotoxic AuI/AuIIIComplexes Derived from 2-(2′-Pyridyl)benzimidazole

Laura Maiore, Maria Carla Aragoni, Carlo Deiana, Maria Agostina Cinellu, Francesco Isaia, Vito Lippolis, Anna Pintus, Maria Serratrice and Massimiliano Arca

Inorg. Chem., 2014, 53, 4068
DOI: 10.1021/ic500022a

Synthesis of Cyclometalated Gold(III) Complexes via Catalytic Rhodium to Gold(III) Transmetalation

Jaime Martín, Enrique Gómez‐Bengoa, Alexandre Genoux and Cristina Nevado

Angewandte Chemie, 2022, 134
DOI: 10.1002/ange.202116755

Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents

Jong Hyun Kim, Evan Reeder, Sean Parkin and Samuel G. Awuah

Sci Rep, 2019, 9
DOI: 10.1038/s41598-019-48584-5

Organometallic d6, d8 and d10 metal complexes for biosensing and imaging, cancer therapy and theranosis

Yam-Yuet Lam, Nga-Sze Lee, Shun-Fung Lee and Clive Yik-Sham Chung

Journal of Organometallic Chemistry, 2024, 1005, 122982
DOI: 10.1016/j.jorganchem.2023.122982

Investigation of the potential anticancer immune response for gold compounds

Mianli Bian, Zhenfan Wen, Jing Shi and Wukun Liu

Chinese Chemical Letters, 2026, 112596
DOI: 10.1016/j.cclet.2026.112596

Proteomic strategies for characterizing ubiquitin-like modifications

Chongyang Li, Trent G. Nelson, Alfred C. O. Vertegaal and Pierre Thibault

Nat Rev Methods Primers, 2021, 1
DOI: 10.1038/s43586-021-00048-9

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

Meng Rui Chang, Egor M. Matnurov, Chengnan Wu, Jemma Arakelyan, Ho-Jung Choe, Vladimir Kushnarev, Jian Yu Yap, Xiu Xuan Soo, Mun Juinn Chow, Walter Berger, Wee Han Ang and Maria V. Babak

J. Am. Chem. Soc., 2025, 147, 7908
DOI: 10.1021/jacs.4c17966

Au(III) Cyclometallated Compounds with 2-Arylpyridines and Their Derivatives or Analogues: 34 Years (1989–2022) of NMR and Single Crystal X-ray Studies

Leszek Pazderski and Pavel A. Abramov

Inorganics, 2023, 11, 100
DOI: 10.3390/inorganics11030100

Structural and spectroscopic studies of Au(III) chloride compounds with 7,8-benzoquinoline

Daria Niedzielska, Leszek Pazderski, Andrzej Wojtczak, Marzena Kurzawa, Jacek Ścianowski and Edward Szłyk

Polyhedron, 2018, 139, 155
DOI: 10.1016/j.poly.2017.09.044

Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib

Aleksandar Pavic, Biljana Đ. Glišić, Sandra Vojnovic, Beata Warżajtis, Nada D. Savić, Marija Antić, Slavko Radenković, Goran V. Janjić, Jasmina Nikodinovic-Runic, Urszula Rychlewska and Miloš I. Djuran

Journal of Inorganic Biochemistry, 2017, 174, 156
DOI: 10.1016/j.jinorgbio.2017.06.009

Antiviral effects and mechanisms against EV71 of the novel 2-benzoxyl-phenylpyridine derivatives

Yanhong Wei, Da Hu, Dong Li, Kanghong Hu, Qian Zhang, Huihui Liu, Qun He, Chenguang Yao, Hanluo Li and Jun Wang

European Journal of Pharmaceutical Sciences, 2023, 186, 106445
DOI: 10.1016/j.ejps.2023.106445

Genome-wide CRISPR Screen Reveal Targets of Chiral Gold(I) Anticancer Compound in Mammalian Cells

Jong Hyun Kim, Samuel Ofori, Abderrahmane Tagmount, Chris D. Vulpe and Samuel G. Awuah

ACS Omega, 2022, 7, 39197
DOI: 10.1021/acsomega.2c05166

Metal-based anticancer chemotherapeutic agents

Nafees Muhammad and Zijian Guo

Current Opinion in Chemical Biology, 2014, 19, 144
DOI: 10.1016/j.cbpa.2014.02.003

Gold(III) Complexes for Antitumor Applications: An Overview

Benoît Bertrand, Morwen R. M. Williams and Manfred Bochmann

Chemistry A European J, 2018, 24, 11840
DOI: 10.1002/chem.201800981

Designing novel Au(III) complexes based on the structure of diazepam: Achieving a multiaction mechanism against glioma

Yanping Li, Haoran Liu, Ronghao Fang, Jiamin Jin, Feng Yang, Jian Chen and Juzheng Zhang

European Journal of Medicinal Chemistry, 2025, 283, 117171
DOI: 10.1016/j.ejmech.2024.117171

Modulating the Chemical Reactivity of Gold Complexes in Living Systems: From Concept to Biomedical Applications

Jia Jiang, Xiaolin Xiong and Taotao Zou

Acc. Chem. Res., 2023, 56, 1043
DOI: 10.1021/acs.accounts.3c00037

Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment

Huanjie Yang, Xin Chen, Kai Li, Hassan Cheaito, Qianqian Yang, Guojun Wu, Jinbao Liu and Q. Ping Dou

Seminars in Cancer Biology, 2021, 68, 105
DOI: 10.1016/j.semcancer.2019.12.013

Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells

Ke-Bin Huang, Feng-Yang Wang, Xiao-Ming Tang, Hai-Wen Feng, Zhen-Feng Chen, Yan-Cheng Liu, You-Nian Liu and Hong Liang

J. Med. Chem., 2018, 61, 3478
DOI: 10.1021/acs.jmedchem.7b01694

Anticancer Profile of a Series of Gold(III) (2‐phenyl)pyridine Complexes

Riccardo Rubbiani, Thomas N. Zehnder, Cristina Mari, Olivier Blacque, Koushik Venkatesan and Gilles Gasser

ChemMedChem, 2014, 9, 2781
DOI: 10.1002/cmdc.201402446

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents

Xin Chen, Qianqian Yang, Lu Xiao, Daolin Tang, Q. Ping Dou and Jinbao Liu

Cancer Metastasis Rev, 2017, 36, 655
DOI: 10.1007/s10555-017-9701-1

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds

Ningning Liu, Hongbiao Huang, Q. Ping Dou and Jinbao Liu

Oncoscience, 2015, 2, 457
DOI: 10.18632/oncoscience.167

Binuclear Biphenyl Organogold(III) Complexes: Synthesis, Photophysical and Theoretical Investigation, and Anticancer Activity

Valerio Giuso, Jeannine Yang, Jérémy Forté, Héloïse Dossmann, Chantal Daniel, Christophe Gourlaouen, Matteo Mauro and Benoît Bertrand

ChemPlusChem, 2023, 88
DOI: 10.1002/cplu.202300303

UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression

Jiahao Liu, Shulu Hu, Junqi Xiao and Jumei Zhou

Cancer Cell Int, 2025, 25
DOI: 10.1186/s12935-025-03884-x

Synthesis of Cyclometalated Gold(III) Complexes via Catalytic Rhodium to Gold(III) Transmetalation

Jaime Martín, Enrique Gómez‐Bengoa, Alexandre Genoux and Cristina Nevado

Angew Chem Int Ed, 2022, 61
DOI: 10.1002/anie.202116755

Bimetallic DppfM(II) (M = Pt and Pd) dithiocarbamate complexes: Synthesis, characterization, and anticancer activity

Shou De Xu and Xiang Hua Wu

Journal of Chemical Research, 2019, 43, 437
DOI: 10.1177/1747519819871029

Synthesis and antitumor activity of gold(I) N-heterocyclic carbene with dithiocarbamate and alkynyl complexes

Qiu Mei Chen, Yanyan Zeng, Ming Rui Zhang, Lingyu Jin, Ping Zhou, Xiang Hua Wu and Wen Xiu Ren

Inorganica Chimica Acta, 2024, 568, 122085
DOI: 10.1016/j.ica.2024.122085

Water‐Soluble Luminescent Cyclometalated Gold(III) Complexes with cis‐Chelating Bis(N‐Heterocyclic Carbene) Ligands: Synthesis and Photophysical Properties

Faan‐Fung Hung, Wai‐Pong To, Jing‐Jing Zhang, Chensheng Ma, Wai‐Yeung Wong and Chi‐Ming Che

Chemistry A European J, 2014, 20, 8604
DOI: 10.1002/chem.201403103

Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications

R. Tyler Mertens, Sailajah Gukathasan, Adedamola S. Arojojoye, Chibuzor Olelewe and Samuel G. Awuah

Chem. Rev., 2023, 123, 6612
DOI: 10.1021/acs.chemrev.2c00649

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Ye-Hong Dou, Shou-De Xu, Yi Chen and Xiang-Hua Wu

Phosphorus, Sulfur, and Silicon and the Related Elements, 2017, 192, 1219
DOI: 10.1080/10426507.2017.1359594

Discovering Proteasomal Deubiquitinating Enzyme Inhibitors for Cancer Therapy: Lessons From Rational design, Nature and Old Drug Reposition

Kush Patel, Zainab SO Ahmed, Xuemei Huang, Qianqian Yang, Elmira Ekinci, Christine M Neslund-Dudas, Bharati Mitra, Fawzy AEM Elnady, Young-Hoon Ahn, Huanjie Yang, Jinbao Liu and Qing Ping Dou

Future Med. Chem., 2018, 10, 2087
DOI: 10.4155/fmc-2018-0091

Deubiquitinases as Anticancer Targets of Gold Complexes

Taotao Zou, Jing‐Jing Zhang, Bei Cao, Ka‐Chung Tong, Chun‐Nam Lok and Chi‐Ming Che

Israel Journal of Chemistry, 2016, 56, 825
DOI: 10.1002/ijch.201600044

Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I)

Zhenghong Peng, David S. Maxwell, Duoli Sun, Basvoju A. Bhanu Prasad, Paul T. Schuber, Ashutosh Pal, Yunming Ying, Dongmei Han, Liwei Gao, Shimei Wang, Alexander Levitzki, Vaibhav Kapuria, Moshe Talpaz, Matthew Young, Hollis D. Showalter, Nicholas J. Donato and William G. Bornmann

Bioorganic & Medicinal Chemistry, 2014, 22, 1450
DOI: 10.1016/j.bmc.2013.12.048

UCH-L3 structure and function: Insights about a promising drug target

Noha Hafez, Zahraa Modather El-Awadly and Reem K. Arafa

European Journal of Medicinal Chemistry, 2022, 227, 113970
DOI: 10.1016/j.ejmech.2021.113970